Sinopharm decides not to take China Traditional Chinese Medicine private

Sinopharm decides not to take China Traditional Chinese Medicine private

Photo by Diana Polekhina on Unsplash

China Traditional Chinese Medicine Holdings said on Wednesday its parent Sinopharm had decided not to proceed with a possible privatisation of the Chinese medicine maker.

Earlier this year, Reuters had reported that a consortium led by Sinopharm planned to take China Traditional Chinese Medicine Holdings (China TCM) private, in a deal that valued the firm at least $3.3 billion at the time.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter